磁共振成像
超极化(物理学)
药物发现
分子成像
磁共振造影剂
体内
核磁共振
磁共振光谱成像
计算机科学
生物医学工程
医学
放射科
核磁共振波谱
生物信息学
生物
物理
生物技术
作者
Dorota Bartusik‐Aebisher,Zuzanna Bober,Jolanta Zalejska–Fiolka,Aleksandra Kawczyk‐Krupka,David Aebisher
出处
期刊:Molecules
[Multidisciplinary Digital Publishing Institute]
日期:2022-10-01
卷期号:27 (19): 6493-6493
被引量:10
标识
DOI:10.3390/molecules27196493
摘要
The continuous development of magnetic resonance imaging broadens the range of applications to newer areas. Using MRI, we can not only visualize, but also track pharmaceutical substances and labeled cells in both in vivo and in vitro tests. 1H is widely used in the MRI method, which is determined by its high content in the human body. The potential of the MRI method makes it an excellent tool for imaging the morphology of the examined objects, and also enables registration of changes at the level of metabolism. There are several reports in the scientific publications on the use of clinical MRI for in vitro tracking. The use of multinuclear MRI has great potential for scientific research and clinical studies. Tuning MRI scanners to the Larmor frequency of a given nucleus, allows imaging without tissue background. Heavy nuclei are components of both drugs and contrast agents and molecular complexes. The implementation of hyperpolarization techniques allows for better MRI sensitivity. The aim of this review is to present the use of multinuclear MRI for investigations in drug delivery.
科研通智能强力驱动
Strongly Powered by AbleSci AI